Table 5.

All-cause mortality and ACC-specific mortality Cox models (univariable analysis).

	Event/available (n)	HR	95% CI	P value
All-cause mortality
ENSAT stage 4 (vs stage 1–3)	48/174	5.61	3.11–10.11	<0.001
Lymph node metastasis (yes)	32/65	2.45	1.19–5.05	0.016
Adrenalectomy (yes)	55/200	0.11	0.06–0.19	<0.001
Pathology
Venous invasion (yes)	25/107	2.67	1.17–6.06	0.019
Sinusoid invasion (yes)	17/60	5.50	1.93–15.71	0.001
Capsular invasion (yes)	27/123	3.28	1.13–9.54	0.029
ACC-specific mortality
CT size	42/178	1.01	1.00–1.01	0.043
CT pre-contrast HU	16/73	1.04	1.01–1.08	0.009
ENSAT stage 4 (vs. stage 1–3)	38/174	5.62	2.89–10.90	<0.001
Hypercortisolism (yes)	25/113	2.76	1.13–6.71	0.025
Lymph node metastasis (yes)	25/65	2.81	1.22–6.47	0.015
Adrenalectomy (yes)	44/200	0.08	0.044–0.16	<0.001
Adjuvant therapy after surgery (yes)a	9/95	4.76	1.19–19.03	0.027
Pathology
Venous invasion (yes)	19/107	3.29	1.24–8.71	0.016
Sinusoid invasion (yes)	13/60	12.77	2.81–58.03	0.001

Only statistically significant variables are listed.

^aAdjuvant therapy was analyzed in patient with complete surgical removal.